658 related articles for article (PubMed ID: 9987089)
1. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients.
Zimmermann J; Herrlinger S; Pruy A; Metzger T; Wanner C
Kidney Int; 1999 Feb; 55(2):648-58. PubMed ID: 9987089
[TBL] [Abstract][Full Text] [Related]
2. Inflammation predicts all-cause and cardiovascular mortality in haemodialysis patients.
Selim G; Stojceva-Taneva O; Zafirovska K; Sikole A; Gelev S; Dzekova P; Stefanovski K; Koloska V; Polenakovic M
Prilozi; 2006 Jul; 27(1):133-44. PubMed ID: 16985487
[TBL] [Abstract][Full Text] [Related]
3. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure.
Stenvinkel P; Heimbürger O; Paultre F; Diczfalusy U; Wang T; Berglund L; Jogestrand T
Kidney Int; 1999 May; 55(5):1899-911. PubMed ID: 10231453
[TBL] [Abstract][Full Text] [Related]
4. Correlation of Inflammation and Lipoprotein (a) with Hypercoagulability in Hemodialysis Patients.
Topçiu-Shufta V; Haxhibeqiri V; Begolli L; Baruti-Gafurri Z; Veseli S; Haxhibeqiri S; Miftari R; Kurti L; Avdiu D
Med Arch; 2015 Aug; 69(4):232-5. PubMed ID: 26543308
[TBL] [Abstract][Full Text] [Related]
5. Determinants of albumin concentration in hemodialysis patients.
Kaysen GA; Stevenson FT; Depner TA
Am J Kidney Dis; 1997 May; 29(5):658-68. PubMed ID: 9159298
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein profile, lipoprotein-associated phospholipase A2 and cardiovascular risk in hemodialysis patients.
Rolla R; De Mauri A; Valsesia A; Vidali M; Chiarinotti D; Bellomo G
J Nephrol; 2015 Dec; 28(6):749-55. PubMed ID: 25971848
[TBL] [Abstract][Full Text] [Related]
7. High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients.
Longenecker JC; Klag MJ; Marcovina SM; Liu YM; Jaar BG; Powe NR; Fink NE; Levey AS; Coresh J
J Am Soc Nephrol; 2005 Jun; 16(6):1794-802. PubMed ID: 15800123
[TBL] [Abstract][Full Text] [Related]
8. Apo(a)-isoform size, nutritional status and inflammatory markers in chronic renal failure.
Stenvinkel P; Heimbürger O; Tuck CH; Berglund L
Kidney Int; 1998 May; 53(5):1336-42. PubMed ID: 9573549
[TBL] [Abstract][Full Text] [Related]
9. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.
Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A
Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein (a) as an acute phase reactant in patients on chronic hemodialysis.
Topciu Shufta V; Begolli L; Kryeziu E
Bosn J Basic Med Sci; 2010 Feb; 10(1):19-25. PubMed ID: 20192926
[TBL] [Abstract][Full Text] [Related]
11. [Nutritional status, comorbidity, and inflammation in hemodialysis].
Fernández-Reyes MJ; Alvarez-Ude F; Sánchez R; Mon C; Iglesias P; Vázquez A
Nefrologia; 2000; 20(6):540-9. PubMed ID: 11217649
[TBL] [Abstract][Full Text] [Related]
12. Inflammation and cardiovascular risk in dialysis patients.
Wanner C; Zimmermann J; Schwedler S; Metzger T
Kidney Int Suppl; 2002 May; (80):99-102. PubMed ID: 11982822
[TBL] [Abstract][Full Text] [Related]
13. Association of lipid and inflammatory markers with C-reactive protein in cardiovascular risk assessment for primary prevention.
Jovicić S; Ignjatović S; Dajak M; Kangrga R; Majkić-Singh N
Clin Lab; 2009; 55(11-12):411-9. PubMed ID: 20225663
[TBL] [Abstract][Full Text] [Related]
14. Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients.
Qureshi AR; Alvestrand A; Divino-Filho JC; Gutierrez A; Heimbürger O; Lindholm B; Bergström J
J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S28-36. PubMed ID: 11792759
[TBL] [Abstract][Full Text] [Related]
15. Ceruloplasmin and acute phase protein levels are associated with cardiovascular disease in chronic dialysis patients.
Panichi V; Taccola D; Rizza GM; Consani C; Migliori M; Filippi C; Paoletti S; Sidoti A; Borracelli D; Panicucci E; Giovannini L
J Nephrol; 2004; 17(5):715-20. PubMed ID: 15593040
[TBL] [Abstract][Full Text] [Related]
16. Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
Johnson BD; Kip KE; Marroquin OC; Ridker PM; Kelsey SF; Shaw LJ; Pepine CJ; Sharaf B; Bairey Merz CN; Sopko G; Olson MB; Reis SE;
Circulation; 2004 Feb; 109(6):726-32. PubMed ID: 14970107
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients.
Helal I; Smaoui W; Hamida FB; Ouniss M; Aderrahim E; Hedri H; Elyounsi F; Maiz HB; Abdallah TB; Kheder A
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):59-62. PubMed ID: 20061694
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress, inflammation and cardiovascular mortality in haemodialysis--role of seniority and intravenous ferrotherapy: analysis at 4 years of follow-up.
Bayés B; Pastor MC; Bonal J; Foraster A; Romero R
Nephrol Dial Transplant; 2006 Apr; 21(4):984-90. PubMed ID: 16326744
[TBL] [Abstract][Full Text] [Related]
19. Atherogenic lipid profile and lipoprotein(a) in relation to serum albumin in haemodialysis patients.
Yang WS; Kim SB; Min WK; Park S; Lee MS; Park JS
Nephrol Dial Transplant; 1995; 10(9):1668-71. PubMed ID: 8559487
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
